Daisanrin(SH 603233, closing price: 34.66 yuan) Released on the evening of December 2announcementsay,DaisanrinPharmaceutical Group Co., Ltd. received company holdings on December 1, 2021shareholderMr. Ke Zhou, Ms. Liang Xiaoling and Ms. Wang Chunchan, one of the persons acting in concert inbig dealA total of 2.83 million shares of the company were reduced, accounting for 0.3581% of the company’s total share capital; Ms. Liang Xiaoling, from November 22, 2021 to December 1, 2021, reduced the company’s holdings by a total of about 282 shares through block transactions and call auctions 10,000 shares, accounting for 0.3572% of the company’s total share capital; Ms. Wang Chunchan, from November 22, 2021 to December 1, 2021, reduced the company’s holdings by a total of approximately 6.63 million shares through block transactions and call auctions.
According to the 2021 annual report,DaisanrinIts main business is pharmaceutical retail and pharmaceutical wholesale, accounting for 91.4% and 5.84% of revenue respectively.
The chairman of Dashenlin is Ke Yunfeng, male, 54 years old, with a master’s degree; the general manager is Ke Guoqiang, male, 39 years old, with a bachelor’s degree.
(Source: Daily Economic News)
Article source: Daily Economic News
Editor in charge: 91
Original title: Da Shenlin: The controlling shareholder’s concerted action persons Ke Zhou, Liang Xiaoling and Wang Chunchan reduced their holdings by approximately 12.29 million shares
Solemnly declare: The purpose of this information is to spread more information, and it has nothing to do with this stand.
report
Scan the QR code to follow
Oriental Wealth Official Website WeChat
.